Compounding Pharmacy Manufacturers Technological Advancements, Revenue Diversification, Patent Expansions, Cross-border Expansion, Performance Gap Identification, Organizational Growth Plans, Operational Excellence

Compounding Pharmacy Companies and Competitive Landscape

The global compounding pharmacy market size was estimated at US$ 13.19 billion in 2023 and is projected to grow to US$ 22.91 billion by 2034, rising at a compound annual growth rate (CAGR) of 5.15% from 2024 to 2034.

Top Companies in the Compounding Pharmacy Market

• Fagron
• Formul8
• Walgreen Co.
• MEDS Pharmacy
• Fusion Apothecary
• Aurora Compounding
• Albertsons Companies
• Apollo Clinical Pharmacy
• Galenic Laboratories Limited (Roseway Labs)
• The London Specialist Pharmacy Ltd (Specialist Pharmacy)
• JL Diekman and AQ Touchard (Fresh Therapeutics Compounding Pharmacy)

Recent Announcements by Industry Leaders

In August 2024, as the telehealth firm diversified into new markets and focused more on weight-loss medications, Hims & Hers decided to purchase a compounding pharmacy.

Recent Developments in the Compounding Pharmacy Market

• In September 2024, Revelation Pharma's compounding network expanded nationwide. The network of 503A and 503B compounding pharmacies introduced a nationwide wholesale service for healthcare providers. One purpose of Revelation Wholesale is to give customers a simplified ordering experience when they buy specialty drugs and compounding solutions.
• In November 2023, a technology startup investment group called Right Side Capital Management made a seed investment in Precision Compounding, a compounding pharmacy with technology that dispenses prescription drugs via telemedicine. Precision Compounding Pharmacy will be better equipped to assist more patients as a result of this investment.

If you have any questions, please feel free to contact us at sales@towardshealthcare.com